Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yingling Zhou
Observed names:
YING-LING ZHOU,
Ying-ling Zhou
Institutions:
Nanjing University of Chinese Medicine,
Nanjing Drum Tower Hospital,
Nanjing University
Observed institutions:
Nanjing University of Chinese Medicine,
Guangdong General Hospital,
Nanjing Drum Tower Hospital,
Guangdong Academy of Medical Sciences,
Southern Medical University,
Nanjing University,
South China University of Technology
show all 7
ORCID:
0000-0002-3153-0739
Observed ORCID:
0000-0002-3153-0739
OpenAlex ID:
A5101785841
Toxicity of nickel ions and comprehensive analysis of nickel ion-associated gene expression profiles in THP-1 cells
2015
·
YING ZHANG
, ZHI-WEI ZHANG
, et al.
·
Molecular Medicine Reports
·
44
PDF
NR3C2‐Related Transcriptome Profile and Clinical Outcome in Invasive Breast Carcinoma
2021
·
Jianjun Lu
, Fang Hu
, et al.
·
BioMed Research International
·
17
PDF
Verteporfin‐Mediated In Situ Nanovaccine Based on Local Conventional‐Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect
2025
·
Zhifan Zhang
, Lin Li
, et al.
·
Advanced Science
·
13
PDF
Predictive value of 18F-FDG PET/CT in patients with acute type B aortic intramural hematoma
2017
·
Fan Yang
, Jianfang Luo
, et al.
·
Journal of Nuclear Cardiology
·
12
Circ-RHOJ.1 regulated myocardial cell proliferation and apoptosis via targeting the miR-124-3p/NRG-1 axis in myocardial ischemia/reperfusion injury
2019
·
Yan Liu
, Xiao Ke
, et al.
·
Archives of Medical Science
·
7
[Increased platelet-leukocyte aggregates in patients with acute coronary syndrome].
2012
·
Da-hao Yang
, Ning Tan
, et al.
·
PubMed
·
5
An investigator-initiated clinical study in patients with refractory or recurrent solid tumors: ‘R-ISV-FOLactis’ trial
2024
·
Juanjuan Dai
, Junmeng Zhu
, et al.
·
Future Oncology
·
2
PDF
An open-label single-center investigator-initiated exploratory clinical study in patients with refractory or recurrent solid tumors: R-ISV-FOLactis trial.
2025
·
Ruojing Lv
, Junmeng Zhu
, et al.
·
Journal of Clinical Oncology
PDF
An open-label single-center investigator-initiated exploratory clinical study in patients with refractory or recurrent solid tumors using SBRT as “in situ vaccination”: R-ISV-FOLactis trial.
2024
·
Rutian Li
, Juanjuan Dai
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
9
Citation count:
100
H-index:
5
I10-index:
4
Year
Topic
Type